| | | | | | What you need to know about the coronavirus today | | | India’s daily infections slow down India reported 72,049 new cases of coronavirus on Wednesday, dropping from the daily highs of last month in a sign infections were peaking for now, officials and experts said.
India leads the world in the average number of new infections and is expected to overtake the United States over the next several weeks as the country with the world’s largest number of cases.
But since it hit a single-day high of 97,894 new cases on Sept. 17, the country has reported a downward trend with 75,909 daily cases on an average, according to a Reuters tally.
China’s experimental vaccine appears safe A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.
In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group’s experimental shot showed no severe adverse reactions.
The most common adverse reactions reported by the trial participants were mild pain, slight fatigue and redness, itching and swelling at the injection site. The candidate also induced immune response.
Czech rise in cases fastest in Europe The Czech Republic reported a record 4,457 new coronavirus cases in a single day, as a spike in infections over the past month is now rising at Europe’s fastest pace.
The daily rise in new COVID-19 cases, recorded on Tuesday, surpassed a previous record of 3,794 to bring the total number of cases recorded since March to 90,022 - a fourfold increase since Aug. 25.
Hospitalizations have soared tenfold in that period to add strain on the healthcare system.
More problems for UK’s testing system Britain’s COVID-19 testing system, already struggling with a surge in new cases, was facing fresh disruption on Wednesday after Swiss pharmaceutical giant Roche said problems at a new warehouse had delayed the dispatch of some products.
Roche is one of the main suppliers of diagnostic tests to Britain’s National Health Service Test and Trace program, which only days ago was hit by a technical glitch that delayed the reporting of 15,000 positive results.
Track the spread of COVID-19 with our global interactive graphic. | | | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |
No comments:
Post a Comment